Direct Prediction of VLCADD Severity Using Newborn Screening Analyte Data
Journal of Inherited Metabolic Disease · 2026
DOI: 10.1002/jimd.70143 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Inherited Metabolic Disease, 2026. Verfasst von Marit Schwantje und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Metabolic Diseases, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, the Netherlands. Hauptthemen laut MEDLINE: Neonatal Screening, Muscular Diseases, Acyl-CoA Dehydrogenase, Long-Chain, Lipid Metabolism, Inborn Errors. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Metakids and PNO zorg.
Abstract (Originalsprache)
A critical concern of newborn screening (NBS) for very‐long chain acyl‐CoA dehydrogenase deficiency (VLCADD) is the difficulty of predicting clinical outcomes. To address this, we investigated neonatal C18:2‐carnitine concentrations as a possible predictor of VLCADD phenotype. To investigate the impact of sex, gestational age (GA) at birth, sampling day and birth weight on C18:2‐carnitine, we analyzed NBS‐dried blood spots (DBS) from Dutch newborns born between 2018 and 2020 ( n = 209.785). After normalization for resulting confounders, C18:2‐carnitine concentrations were investigated in NBS‐DBS ( n = 15) and neonatal plasma ( n = 35) of Dutch VLCADD‐patients, and in German NBS‐DBS ( n = 6) and correlated with clinical severity and diagnostic assays. Results showed that C18:2‐carnitine concentrations were affected by GA, sampling day, birth weight and, to a lesser extent, by sex. High C18:2‐carnitine, normalized for GA, sampling day and birth weight, reliably identified all VLCADD‐patients with (expected) severe phenotypes. The differentiating C18:2‐carnitine was identified as linoleylcarnitine. In conclusion, this study shows that neonatal C18:2‐carnitine concentrations can serve to predict disease severity directly after positive NBS for VLCADD. Patients with high C18:2‐carnitine concentrations can be considered “severe” and require strict dietary treatment and close monitoring. Patients with low C18:2‐carnitine concentrations can be identified as “mild” and only need preventive dietary measures.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Metabolic Diseases, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, the Netherlands.
- Reference Laboratory for Pre- and Neonatal Screening, Centre for Health Protection Bilthoven, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
- Center for Population Screening, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
- Department of Clinical Chemistry and Pediatrics, Laboratory Genetic Metabolic Diseases, Emma Children's Hospital, Amsterdam UMC Location University of Amsterdam, Amsterdam, the Netherlands.
- Amsterdam Gastroenterology Endocrinology Metabolism, Inborn Errors of Metabolism, Amsterdam, the Netherlands.
- Core Facility Metabolomics, Amsterdam UMC Location University of Amsterdam, Amsterdam, the Netherlands.
ORCID-Profile: Marit Schwantje, Sacha Ferdinandusse, Ulrike Mütze, Sabine A Fuchs
Förderung
- Metakids and PNO zorg
Zitieren
APA
Schwantje, M., Maase, R. E., Dekkers, E., Ferdinandusse, S., Vaz, F. M., Hörster, F., Mütze, U., Grünert, S. C., Visser, G., Velden, M. G. M. S., & Fuchs, S. A. (2026). Direct Prediction of VLCADD Severity Using Newborn Screening Analyte Data. Journal of Inherited Metabolic Disease. https://doi.org/10.1002/jimd.70143
Vancouver
Schwantje M, Maase RE, Dekkers E, Ferdinandusse S, Vaz FM, Hörster F, et al. Direct Prediction of VLCADD Severity Using Newborn Screening Analyte Data. Journal of Inherited Metabolic Disease. 2026. doi:10.1002/jimd.70143
BibTeX
@article{Schwantje2026,
author = {Schwantje, Marit and Maase, Rose E and Dekkers, Eugenie and Ferdinandusse, Sacha and Vaz, Frédéric M and Hörster, Friederieke and Mütze, Ulrike and Grünert, Sarah C and Visser, Gepke and Velden, Monique G M De Sain-van der and Fuchs, Sabine A},
title = {Direct Prediction of VLCADD Severity Using Newborn Screening Analyte Data},
journal = {Journal of Inherited Metabolic Disease},
year = {2026},
doi = {10.1002/jimd.70143}
}
EUVIMED